Morphea: an Unusual Case Affecting Lip and Alveolar Bone
Shuangshuang Wu,Jin Li,Wenqing Zhang,Zhimin Yan
DOI: https://doi.org/10.1111/ijd.16840
2023-01-01
International Journal of Dermatology
Abstract:A 24-year-old woman presented to the dental clinic with a 2-year history of receding gums on her upper front teeth. She had no significant family or medical history. Oral examination revealed a linear hypopigmented lesion on the left upper lip mucosa, which extended through the vermilion and attached gingiva of the upper left central and lateral incisors (Figure 1a). Meanwhile, the affected teeth presented labial gingival recession and root exposure with increased mobility (Figure 1b). An x-ray revealed advanced alveolar bone loss (Figure 2). A biopsy of the labial mucosa demonstrated thickening collagen in the lamina propria with lymphomonocytic infiltration, confirming the diagnosis of morphea (Figure 1c). The laboratory examinations including complete blood counts, comprehensive metabolic panel, rheumatoid factors, antinuclear antibodies, and extractable nuclear antigens showed no abnormalities. After treatment with topical tacrolimus ointment for 3 months, the induration of the lesion gradually improved with no evidence of further progression at 1 year of follow-up (Figure 1d). Considering the desire for esthetic rehabilitation of periodontal defects, the patient was referred to the Department of Periodontics for further consultation and evaluation. Periodontal surgery including bone grafts and guided bone regeneration may be considered to restore the loss of alveolar bone following stabilization of the affected lesion. Morphea, also known as localized scleroderma, is a rare chronic connective tissue disease primarily affecting the skin, subcutaneous tissue, bones, and even the central nervous system. It is characterized by excessive collagen deposition leading to thickening and sclerosis of the skin and underlying tissues.1 To date, the etiopathogenesis of morphea remains unclear, and it might be associated with genetic predisposition and multiple environmental triggers including trauma, radiation, infections, and certain medications.1 Clinically, morphea presents typically as well-circumscribed plaques with signs of sclerosis and atrophy. The sclerosing process particularly affects the skin, and cases of morphea with merely oral involvement are rarely reported.2 The clinical presentations of oral involvement in morphea are diverse, encompassing scar-like or pale indurated plaques in oral mucosa, localized gingival recession, delayed tooth eruption, atrophic root development, and even mandibular and/or maxillary resorption.2, 3 In this case, we reported a young female patient with morphea limited to the orofacial region with gingival recession along with resorption of anterior maxilla alveolar bone. A “groove” sign presented at the site of tendons and ligaments, and deep bone tissue loss developed in the atrophic phase. In clinical practice, differential diagnosis of morphea must be considered in addition to trauma and periodontal disease when the patient presents with severe but localized periodontal damage. The diagnosis of morphea with oral involvement is made on clinical features and radiologic imaging with confirmatory histopathology, which is necessary to distinguish it from other entities including lichen sclerosus and scarring.2, 4 It is common for morphea patients to experience delays in diagnosis and treatment because healthcare providers fail to recognize this relatively rare disease. It was reported that 63% were given the diagnosis more than 6 months and 25.5% of patients were diagnosed more than 2 years after disease onset.5 It was indicated that the evaluation of morphea differed depending more on the specialty of the treating physician than on disease characteristics, and solutions for this discrepancy may include narrowing the gap in knowledge and broadening awareness of morphea in more specialties. In conclusion, we reported an unusual case with merely oral involvement of morphea. It is imperative for dermatologists and dentists to improve their ability to distinguish the broad spectrum of clinical presentations of morphea. In the treatment of morphea, strengthening the collaborative relationship between the dermatologist, dentist, and pathologist is preferable.